Form 4: Marimed Inc. President and CEO Jon Levine Reports Stock Transactions

Jon Levine, President and CEO of Marimed Inc., reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, impacting his beneficial ownership of common stock.

Summary

• On April 2, 2025, Jon Levine, President and CEO of Marimed Inc., reported transactions involving the company's common stock.
• 23,041 Restricted Stock Units (RSUs) vested and converted into common stock on a one-for-one basis.
• The company withheld 7,984 shares of common stock to satisfy tax withholding obligations related to the RSU vesting at a price of $0.1.
• Following these transactions, Levine directly owns 20,568,766 shares of common stock.
• Levine also indirectly owns 6,684,640 shares through the Jon Levine Family Trust, but disclaims beneficial ownership of these shares.
• After the reported transactions, Levine directly owns 46,069 Restricted Stock Units (RSU).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of RSUs indicates a form of compensation and alignment of interests between the executive and the company's performance.

Future Outlook

The remaining RSUs will vest in four equal installments every six months thereafter for the following two years in accordance with the terms of an agreement between the Issuer and the Reporting Person.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's common for executives to receive stock-based compensation and for companies to withhold shares for tax purposes.

Stakeholder Impact

• Shareholders are informed about the insider's stock transactions, which can influence their perception of the company's performance and management's confidence.
• The company's financial statements will reflect the impact of stock-based compensation.

Key Dates

Keywords

Form 4, Marimed Inc., MRMD, Jon Levine, Restricted Stock Units, RSU, Beneficial Ownership, Insider Trading, Tax Withholding, Common Stock